Ep.232 - Shake up at BIO. Plus: ASGCT highlights, new IPF & obesity data

BioCentury This Week

English - May 20, 2024 22:00 - 26 minutes - 18.1 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Bonus Content - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more

Next Episode: Ep.233 - ASCO Preview, Rare Diseases & Biogen M&A

New BIO CEO John Crowley is reorganizing BIO in a bid to reshape how the organization communicates and enhance its focus on patients. BioCentury’s editors also recap the 24th annual BioEquity Europe conference that was held in San Sebastian, Spain last week, as well as highlights from last week’s American Society of Gene and Cell Therapy (ASGCT) conference. The editors also discuss impressive early data from Endeavor BioMedicines Inc. in idiopathic pulmonary fibrosis (IPF) and Phase Ib obesity data from Roche.

This week’s podcast is sponsored by Nxera Pharma.

View full story: https://www.biocentury.com/article/652453